Literature DB >> 31498533

Cardiovascular risk stratification in Chinese patients with hypertension.

Weizhong Zhang1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31498533      PMCID: PMC8030626          DOI: 10.1111/jch.13680

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  7 in total

1.  Comments on 2018 ESC/ESH Hypertension Guidelines: Chinese Perspective.

Authors:  Yuqing Zhang; Wenzhong Zhang; Lisheng Liu
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

2.  2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension.

Authors: 
Journal:  J Geriatr Cardiol       Date:  2019-03       Impact factor: 3.327

3.  2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.

Authors:  Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais
Journal:  J Hypertens       Date:  2018-10       Impact factor: 4.844

4.  [2010 Chinese guidelines for the management of hypertension].

Authors:  Li-Sheng Liu
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2011-07

5.  Cardiovascular risk stratification in Chinese patients with hypertension.

Authors:  Weizhong Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-09       Impact factor: 3.738

Review 6.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

7.  Intensified, optimized and standardized management of Chinese patients with hypertension: Comments on "2018 Chinese Guidelines for Prevention and Treatment of Hypertension".

Authors:  Wei-Zhong Zhang
Journal:  J Geriatr Cardiol       Date:  2019-03       Impact factor: 3.327

  7 in total
  1 in total

1.  Cardiovascular risk stratification in Chinese patients with hypertension.

Authors:  Weizhong Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-09       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.